No image

Elecsys CA 15-3 II

Details

Device typeCancer antigen 15-3 (CA15-3) IVD, kit, enzyme immunoassay (EIA): A collection of reagents and other associated materials intended to be used for the qualitative and/or quantitative detection of cancer antigen 15-3 (CA15-3), a marker commonly associated with breast cancer, in a clinical specimen using an enzyme immunoassay (EIA) method.

FDA categorySystem, test, immunological, antigen, tumor

Device ID07613336218334

Catalog number09755594190

AvailabilityPrescription

MRI safetyLabeling does not contain MRI Safety Information

Contact

No contact is listed for this device.

Related products

Product	Model	Company	Device type
ARCHITECTAbbott GmbHCancer antigen 15-3 (CA15-3) IVD, kit, chemiluminescent immunoassay	02K4437	Abbott GmbH	Cancer antigen 15-3 (CA15-3) IVD, kit, chemiluminescent immunoassay
Elecsys IGFBP-3Roche Diagnostics GmbHInsulin-like growth factor binding protein 3 (IGFBP-3) IVD, kit, chemiluminescent immunoassay	07574690190	Roche Diagnostics GmbH	Insulin-like growth factor binding protein 3 (IGFBP-3) IVD, kit, chemiluminescent immunoassay
CA-125 AccuBind ELISA Test System - 96 WellsMonobind, Inc.Cancer antigen 125 (CA125) IVD, kit, enzyme immunoassay (EIA)	3025-300	Monobind, Inc.	Cancer antigen 125 (CA125) IVD, kit, enzyme immunoassay (EIA)
CEA-NG AccuBind ELISA Test System - 192 WellsMonobind, Inc.Carcinoembryonic antigen (CEA) IVD, kit, enzyme immunoassay (EIA)	4625-300	Monobind, Inc.	Carcinoembryonic antigen (CEA) IVD, kit, enzyme immunoassay (EIA)